#Antibodies

Rafael Fonseca MD

Rfonsi1

*** 𝙏𝙝𝙚 𝘾𝙊𝙑𝙄𝘿-19 𝙥𝙖𝙣𝙙𝙚𝙢𝙞𝙘 𝙬𝙞𝙡𝙡 𝙚𝙣𝙙 *** One possible analysis of recent data would suggest that there is an end in sight (cannot be soon enough) and that perhaps that

Alastair McAlpine, MD

AlastairMcA30

As requested by the awesome @sindivanzyl - here’s a SUPER beginner’s guide to the immune system (to help you understand vaccines).Thread (For this thread, pathogen = bacteria, virus, parasite

Joseph Allen

j_g_allen

THREAD on positive #COVIDー19 developments(I try to keep a runny tally in my head - helps get through the days, knowing there is a light at the end)1. Therapeutics are

Craig Wilen

WilenLab

Excited to share our new paper led by @chennifer_jen looking at the role of NSAIDs in #COVID19. NSAIDs dampen the cytokine and antibody response to SARS-CoV-2 infection @ASMicrobiology @JVirology @Yale_LabMed

Mac n’ Chise 🧬🧫🦠

sailorrooscout

Undoubtedly there is going to be a lot of conversation surrounding the new viral variants. This is me being completely transparent when I say this: please don’t panic. The most

Jeremy Farrar

JeremyFarrar

World needs to know. A text this evening from colleague in middle income country. "We have a disaster here. Hospitals overwhelmed, critical oxygen shortages, soaring COVID numbers. New variant SARS-

Simon Cleary

Simon_J_Cleary

New research out in @JClinicalInvest! Critical roles for endothelial antigen and complement in a model of antibody-mediated lung injury + imaging of #ARDS lung pathology initiation #InMice @UCSF @immunox. Free

John Cody, MD

JPCodyMD

In response to some very heated and triggered people out there, please feel free to read the following, and know that I will absolutely not respond to or regard any

Bloom Lab

jbloom_lab

Our complete mapping of mutations to #SARSCoV2 RBD that reduce binding by convalescent human plasma is out in @cellhostmicrobe (https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(21)00082-2). Right now E484K getting lot of attention

Shannon Young

SYoungReports

Mexican health authorities are presenting preliminary findings of limited serological surveys for SARS-CoV-2. Findings: of the samples studied, nearly 25% tested positive for antibodies. Around 70% of those testing positive

Shane Crotty

profshanecrotty

1/ Our newest COVID-19 immunology work is online today at Cell! @ljiresearch https://www.cell.com/cell/fulltext/S0092-8674(20)31235-6 2/ We aimed to better understand hospitalized COVID-19 cases by examining virus-specific immune responses

Nicholas A. Christakis

NAChristakis

Let’s talk about a COVID19 seroprevalence study, this time well conducted (it seems), which provides a petri-dish type natural experiment. It’s the small Austrian mountain ski village of Ischgl, one of the epicenters of SARSCoV2.

Gummi Bear

gummibear737

Stockholm is the best population to test Covid theory whereby it was hit hard early and did not have lockdowns.Nobel Prize winner Dr Michael Levitt postulated that the virus burns

Eric Feigl-Ding

DrEricDing

BREAKING—A new #SARSCoV2 variant (aka B.1.1.248) identified by Japan in pax from Brazil . This new one has both the more infectious N501Y mutation (not affect vaccine), as well

i am not defined by my hiv status

niqitapieterse

HOW DOES HIV SPREAD DURING SEX?To spread HIV during sex, HIV infection in blood or sexual fluids must be transmitted to someone. Sexual fluids come from a man’s penis or

Cornelius Traas

theapplefarmer

A thread on vaccines:Most of us have been vaccinated quite a few times in our lives. As a young child I remember getting the Polio vaccine at “the dispensary” on

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.